Author:
Baxi Kalgi,Majmundar Drumil,Patel Ani,Chandibhamar Vidhi,Patel Nayan,Majmundar Vidit
Reference12 articles.
1. Pharmacokinetics of diacerein in patients with liver cirrhosis;Magnard;Biopharm Drug Dispos,1993
2. Martel-Pelletier J, Pelletier JP Effects of diacerein at the molecular level in the osteoarthritis disease process. Ther Adv Musculoskelet Dis 2010;2:95-104.
3. Pavelka K, Bruyère O, Cooper C, Kanis JA, Leeb BF, Maheu E, et al. Diacerein: Benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO. Drugs Aging 2016;33:75-85.
4. Kumar KK, Sasikanth K, Sabareesh M, Dorababu N Formulation and evaluation of diacerein cream. Asian J Pharm Clin Res 2011;4:93-8.
5. Napoli GD Patent analyzing system (EP1248608B1). European Patent Office, 26 November 2003. EPA.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献